Valeritas gets C Mark OK for disposable insulin device; Carticept gets FDA clearance for Navigator;

> New Jersey-based Valeritas has received European C Mark approval for its V-Go disposable insulin delivery device. Release

> Carticept Medical, based in Georgia, has received FDA clearance to market its Navigator computer controlled drug delivery system. Article

> Micell Technologies has finished enrolling patients in its DESSOLVE II CE Mark clinical study of the MiStent Drug-Eluting Coronary Stent System. The Durham, NC company has enrolled 183 patients across 26 centers throughout Europe and New Zealand. Release

> Drug delivery patent of the week: Pharmaceutical compositions and methods for delivering nucleic acids into cells. Patent

Suggested Articles

Takeda forged a feasibility pact to see whether it could pair a plasma-based therapy with Elektrofi's microparticle delivery tech.

RNA nanoparticles can squeeze into tumors and exit swiftly through the kidney, perfect for targeted delivery of cancer drugs, an OSU team says.

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.